Physician profile
Cameron Dezfulian
NPI 1578563565
$1,250.36
in general payments reported to CMS, 2019-2025
10 companies · $33.98 in 2025
The $33.98 reported for 2025 was less than what a typical Pediatric Critical Care Medicine provider received nationally (typical 2025 total: $71.68).
See the full distribution for Pediatric Critical Care Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $74.23 · 2024: $1,142 · 2025: $33.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.36 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $512.52 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| W. L. Gore & Associates, INC. | $207.41 | 2024 | Gore Cardioform Septal Occluder |
| Medtronic, INC. | $167.36 | 2024 | Harmony, Invos |
| Astrazeneca Pharmaceuticals LP | $117.72 | 2024 | |
| Getinge USA Sales, LLC | $96.14 | 2024 | Base Unit Servo-U |
| Angiodynamics, INC. | $58.39 | 2024-2025 | Alphavac |
| Abiomed | $50.09 | 2023 | Impella |
| Abbott Laboratories | $40.73 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Dezfulian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.